Goldman Sachs Group Inc Armata Pharmaceuticals, Inc. Call Options Transaction History
Goldman Sachs Group Inc
- $706 Billion
- Q2 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding ARMP
# of Institutions
28Shares Held
730KCall Options Held
0Put Options Held
0-
Vanguard Group Inc Valley Forge, PA260KShares$1.27 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA105KShares$511,2290.0% of portfolio
-
Edgewood Management LLC Greenwich, CT100KShares$488,9990.0% of portfolio
-
Bridgeway Capital Management, LLC Houston, TX44.7KShares$218,4940.0% of portfolio
-
State Street Corp Boston, MA40.3KShares$197,0670.0% of portfolio
About Armata Pharmaceuticals, Inc.
- Ticker ARMP
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,144,700
- Market Cap $177M
- Description
- Armata Pharmaceuticals, Inc., a clinical-stage biotechnology company, focuses on the development of targeted bacteriophage therapeutics for antibiotic-resistant infections worldwide. It develops its products using its proprietary bacteriophage-based technology. The company's product candidates include AP-SA02 for the treatment of Staphylococcus ...